Watson Pharmaceuticals: Pfizer Seeks To Block Generic Viagra
samsung1
Ohio
The company said Thursday it has applied for regulatory approval to sell its sildenafil citrate tablets, a generic version of Pfizer's erectile-dysfunction treatment.
But it said Pfizer filed suit Wednesday to prevent Watson's commercializing the competitor prior to a patent expiration.
A Pfizer representative wasn't able to comment immediately on the matter.
Viagra accounted for $1.93 billion in sales for Pfizer last year, representing about 2.8% of total revenue.
Watson shares were up 0.2% at $64.04 after hours while Pfizer's were up 1 cent at $21.01.
http://online.wsj.com/article/BT-CO-2011…
Got something to say?
Start your own discussion
6 comments
Latest
Here are the details on the Viagra patent:
http://www.accessrx.com/research/viagra-…
http://www.bloomberg.com/apps/news?pid=n…